- Home
- A-Z Publications
- Current Cancer Drug Targets
- Previous Issues
- Volume 23, Issue 1, 2023
Current Cancer Drug Targets - Volume 23, Issue 1, 2023
Volume 23, Issue 1, 2023
-
-
Present and Future Prospects of the Anti-cancer Activities of Saikosaponins
Authors: Li-Xia Xiao, Hui-Nian Zhou and Zuo-Yi JiaoSince their discovery, saikosaponins (SSs) have been found to play an important role in treating a variety of cancers via diverse mechanisms of action. This review summarizes the current research status and prospects of the anti-cancer activities of SSs, providing novel insights into the limitations of current studies. In addition, it discusses whether SSs can be applied in immunotherapy and the possible mechanisms by wh Read More
-
-
-
Targeting the Transforming Growth Factor-beta Signaling Pathway in the Treatment of Gynecologic Cancer
The transforming growth factor-beta (TGF-β) signaling pathway has been reported to be dysregulated in the pathogenesis of several malignancies, including gynecologic cancers. This provides proof of concept of its potential value as a therapeutic target and prognostic biomarker in cervical cancer. Here we provide an overview of the biological role and clinical impact of TGF-β inhibitors either as a single agent or as a combin Read More
-
-
-
Aminopeptidases in Cancer, Biology and Prospects for Pharmacological Intervention
Aminopeptidases, which catalyze the cleavage of amino acids from the amino terminus of proteins, are widely distributed in the natural world and play a crucial role in cellular processes and functions, including metabolism, signaling, angiogenesis, and immunology. They are also involved in the homeostasis of amino acids and proteins that are required for cellular proliferation. Tumor cells are highly dependent on the exogenous Read More
-
-
-
Recent Progress in Histone Deacetylase (HDAC) 1 Inhibitors as Anticancer Agent
Histone deacetylases (HDACs) are essential for maintaining homeostasis by catalyzing histone deacetylation. Aberrant expression of HDACs is associated with various human diseases. Although HDAC inhibitors are used as effective chemotherapeutic agents in clinical practice, their applications remain limited due to associated side effects induced by weak isoform selectivity. HDAC1 displays unique structure and cellu Read More
-
-
-
Genome-Wide CRISPR-Cas9 Screening and Identification of Potential Genes Promoting Prostate Cancer Growth and Metastasis
Authors: Wei Wang, Dongbo Yuan, Kehua Jiang, Ruidong Li, Han Qu, Fu-Neng Jiang, Wei-De Zhong, Fa Sun, Zhenyu Jia and Jianguo ZhuObjective: Identification and validation of genes that functionally account for the growth and metastasis of prostate cancer. Methods: DU145-KO cell line was constructed by transfecting DU145 cells with lentivirus packaged with the genome-wide knock-out library. The DU145-KO cells were transplanted into the armpits of immunocompromised Nu/Nu mice, followed by the tissue collection from the lung at week 3 (early lung Read More
-
Volumes & issues
-
Volume 25 (2025)
-
Volume 24 (2024)
-
Volume 23 (2023)
-
Volume 22 (2022)
-
Volume 21 (2021)
-
Volume 20 (2020)
-
Volume 19 (2019)
-
Volume 18 (2018)
-
Volume 17 (2017)
-
Volume 16 (2016)
-
Volume 15 (2015)
-
Volume 14 (2014)
-
Volume 13 (2013)
-
Volume 12 (2012)
-
Volume 11 (2011)
-
Volume 10 (2010)
-
Volume 9 (2009)
-
Volume 8 (2008)
-
Volume 7 (2007)
-
Volume 6 (2006)
-
Volume 5 (2005)
-
Volume 4 (2004)
-
Volume 3 (2003)
-
Volume 2 (2002)
-
Volume 1 (2001)
Most Read This Month
Article
content/journals/ccdt
Journal
10
5
false
en
